US74275C3043 - Common Stock
PROCESSA PHARMACEUTICALS INC
NASDAQ:PCSA (5/16/2024, 2:04:19 PM)
1.99
-0.03 (-1.49%)
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. The company is headquartered in Hanover Maryland, Maryland and currently employs 15 full-time employees. The company went IPO on 2013-10-07. The firm is focused on utilizing the Processa Regulatory Science Approach, including the principles associated with food and drug administration (FDA’s) project Optimus Oncology initiative and the related FDA Draft Guidance, in the development of next generation chemotherapy (NGC) oncology drug products. Its pipeline consists of three oncology drugs (NGC-Capecitabine, NGC-Gemcitabine and NGC-Irinotecan) and two non-oncology drugs (PCS12852 and PCS499). NGC-Capecitabine is an orally administered irreversible inhibitor of the enzyme dihydropyrimidine dehydrogenase (DPD). NGC-Gemcitabine is an oral analog of gemcitabine that is converted to its active metabolite by a different enzyme system than gemcitabine resulting in a positive response in gemcitabine patients as well as some gemcitabine treatment-resistant patients. NGC-Irinotecan is a prodrug of the active metabolite of irinotecan (SN-38).
PROCESSA PHARMACEUTICALS INC
7380 Coca Cola Dr Ste 106
Hanover Maryland MARYLAND 21076
P: 14437763133
CEO: David Young
Employees: 15
Processa Pharma just reported results for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Processa Pharma (NASDAQ:PCSA) just reported results for the first quarter of 20...
HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...
Brings extensive experience in all phases of oncology drug development HANOVER, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc....
Which stocks are moving before the opening bell on Friday?
HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...
Here you can normally see the latest stock twits on PCSA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: